地塞米松应用于肿瘤治疗的研究进展王丽杰卢炜周田彦-药学学报.PDF
文本预览下载声明
地塞米松应用于肿瘤治疗的研究进展
王丽杰, 卢炜, 周田彦*1
(北京大学药学院药剂学系, 北京 100191)
摘要: 地塞米松是临床上广泛使用的糖皮质激素,其具有多种药理作用。近
年来,地塞米松在癌症治疗中的应用日益增多,它可预防和缓解化疗药物带来的
恶心、呕吐和疼痛等副作用;也可作为药物增敏剂来增强化疗药物的抗肿瘤效果,
还在某些癌症治疗中用作抗肿瘤药物。地塞米松通过与糖皮质激素受体结合而介
导多种信号通路,从而发挥抗炎、抗血管生成和激素调节等多种作用,对肿瘤的
增殖、侵袭和转移等过程产生影响。
关键词: 地塞米松; 糖皮质激素; 肿瘤; 炎症; 糖皮质激素受体
Current applications of dexamethasone for cancer treatment
*
WANG Li-jie, LU Wei, ZHOU Tian-yan
(Department of Pharmacuetics, School of Pharmaceutical Science, Peking University,
Beijing 100191, China)
Abstract: Dexamethasone is a synthetic glucocorticoid that is widely used in
clinical due to its multiple pharmacological effects. Recently, dexamethasone is
increasingly being utilized in anti-cancer therapy. It is frequently used to prevent
side effects of chemotherapy such as nausea, vomiting and pain, as well as to increase
the anti-tumor activity of the cancer chemotherapeutic agents as a chemosensitizer
and to inhibit tumor growth as an anti-cancer agent in some certain cancers.
Dexamethasone produces the effect of anti-inflammatory, anti-angiogenesis, estrogen
regulation and so on, by binding to glucocorticoid receptor to regulate gene
expression of some important bio-signal molecules. Those signal pathways could
interfere with the transcription of various factors which can regulate proliferation,
invasion and metastasis of tumors.
Key words: dexamethasone; glucocorticoid; cancer; inflammation;
glucocorticoid receptor
收稿日期: 2015-06-24; 修回日期: 2015-07-27.
基金项目: 国家自然科学基金 .
*通讯作者Tel: 86-10 Fax: 86-10 E-mail: tianyanzhou@
地塞米松 (dexamethasone, DEX) 是一种人工合成、临床使用广泛的长效糖
皮质激素,是泼尼松龙的氟化衍生物,分子式为C
显示全部